222 related articles for article (PubMed ID: 87418)
21. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
[TBL] [Abstract][Full Text] [Related]
22. Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function.
Miller RA; Stutman O
Eur J Immunol; 1981 Oct; 11(10):751-6. PubMed ID: 6975716
[TBL] [Abstract][Full Text] [Related]
23. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
DeKruyff R; Clayberger C; Cantor H; Dorf ME
J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
[TBL] [Abstract][Full Text] [Related]
24. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
Handa K; Herrmann S
J Immunol; 1985 Sep; 135(3):1564-72. PubMed ID: 2410495
[TBL] [Abstract][Full Text] [Related]
25. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid.
Vitetta ES; Hart DA; Forman J
J Immunol; 1978 Sep; 121(3):997-1001. PubMed ID: 690447
[TBL] [Abstract][Full Text] [Related]
26. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
Dennert G; Hatlen LE
J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
[TBL] [Abstract][Full Text] [Related]
27. Role of self carriers in the immune response and tolerance. VI. Induction and reversal of TNP-modified self unresponsiveness in vitro.
Li JT; Scott DW
J Immunol; 1980 Dec; 125(6):2380-4. PubMed ID: 6968782
[TBL] [Abstract][Full Text] [Related]
28. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
29. The clonal analysis of cytotoxic lymphocytes against 2,4,6-trinitrophenyl (TNP)-modified cells.
Ching LM; Marbrook J
Eur J Immunol; 1979 Jan; 9(1):22-7. PubMed ID: 86448
[TBL] [Abstract][Full Text] [Related]
30. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells.
Finberg R; Burakoff SJ; Benacerraf B; Greene MI
J Immunol; 1979 Sep; 123(3):1210-4. PubMed ID: 89165
[TBL] [Abstract][Full Text] [Related]
31. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
Henkart PA; Schmitt-Verhulst M; Shearer GM
J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
[TBL] [Abstract][Full Text] [Related]
32. The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens.
Teh HS; Teh SJ
J Immunol; 1980 Nov; 125(5):1977-86. PubMed ID: 6159396
[TBL] [Abstract][Full Text] [Related]
33. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
[TBL] [Abstract][Full Text] [Related]
34. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
Forman J
J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
[TBL] [Abstract][Full Text] [Related]
35. The extent of self-MHC restriction of cytotoxic T cells in nude mice varies from mouse to mouse.
Miller RG; Derry HR; Sarjeant BJ
J Immunol; 1983 Jan; 130(1):63-6. PubMed ID: 6600197
[TBL] [Abstract][Full Text] [Related]
36. Role of accessory cells in B cell activation. I. Macrophage presentation of TNP-Ficoll: evidence for macrophage-B cell interaction.
Boswell HS; Sharrow SO; Singer A
J Immunol; 1980 Feb; 124(2):989-96. PubMed ID: 6965395
[TBL] [Abstract][Full Text] [Related]
37. Synergy between subpopulations of normal mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity specific for "modified self" antigens.
Hodes RJ; Hathcock KS; Shearer GM
J Immunol; 1975 Oct; 115(4):1122-5. PubMed ID: 51877
[TBL] [Abstract][Full Text] [Related]
38. Cellular and genetic control of antibody responses. VI. Expression of Ir gene function by H-2a accessory cells, but not H-2a T or B cells in responses to TNP-(T,G)-A--L.
Hodes RJ; Hathcock KS; Singer A
J Immunol; 1979 Dec; 123(6):2823-9. PubMed ID: 115922
[No Abstract] [Full Text] [Related]
39. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. I. Effector cells can recognize two distinct classes of hapten-reactive self sites on cell surface proteins.
Levy RB; Shearer GM; Richardson JC; Henkart PA
J Immunol; 1981 Aug; 127(2):523-8. PubMed ID: 6972967
[TBL] [Abstract][Full Text] [Related]
40. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
Davignon JL; Guimezanes A; Schmitt-Verhulst AM
J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
